VEINOPLUS® is a prescription neuromuscular electrical stimulation device. Among its cleared indications: prevention or retardation of muscle disuse atrophy.
Podiatry, foot and ankle surgery, orthopedic trauma.
Prevention or retardation of muscle disuse atrophy.
At home, seated, operated by the patient on a prescribed schedule.
Casting, bracing and non-weight-bearing orders take the calf out of use for weeks at a time. The repair is protected; the muscle doing the work of venous return is not.
The gastrocnemius and soleus are no longer being asked to work. What is left is disuse atrophy of the calf: measurable circumference loss, weakness and a deconditioned limb — in a leg whose motor supply is still intact.
Where the disuse has a non-neurological cause and the motor supply is intact, prevention or retardation of muscle disuse atrophy is a cleared indication for this device.
Electrodes are placed over the calf. The device produces rhythmic, visible contractions of the gastrocnemius and soleus while the patient is seated — no gym, no weight-bearing requirement, and nothing the patient has to be able to walk to do.
A brisk visible contraction on an in-office trial demonstrates that the motor supply is intact.
A patient in a cast or boot, or recently out of one, with visible or measurable calf wasting.
Place electrodes over the calf and confirm a brisk visible gastrocnemius / soleus contraction.
The clinical findings and trial response, charted as you normally would.
Home-use protocol. C2 Medical handles fulfilment and patient set-up — nothing is stocked or fitted in your office.
Relaxation of muscle spasms; prevention or retardation of muscle disuse atrophy; increasing local blood circulation; muscle re-education; immediate post-surgical stimulation of calf muscles to prevent venous thrombosis; maintaining or increasing range of motion.
Cardiac pacemaker or other implanted electronic device. Active DVT at the treatment site. Severe arterial insufficiency. Uncontrolled congestive heart failure.
Low-intensity impulses, with a waveform designed for patient comfort during stimulation. Refer to the instructions for use for complete warnings and precautions. The device is non-invasive, drug-free and patient-administered.
Ten peer-reviewed publications and 49 international congress presentations are reported by DynaPulse Medical. Selected references are listed below for reference only; full texts are available on request.
No. The device ships to the patient. Nothing is held or managed by the practice.
Only the in-office trial. There is no fitting appointment and no supervised treatment session.
No. It is used alongside the plan you already set, for the patient who cannot yet tolerate ambulation-based reconditioning.
The instructions for use, indication details and ordering information — all available on request.
Instructions for use, indication details and ordering information. Clinicians and practice staff can request them directly.